Literature DB >> 31965113

Pleural chondroid metaplasia in a background of IgG4 plasma cell rich chronic inflammatory infiltrate: report of a rare case with review of literature.

M Spinelli1, A Datta2, M A Montero Fenandez3, P Viola4.   

Abstract

Mesothelial reactive and degenerative changes secondary to inflammatory conditions, toxin exposure, neoplastic and non-neoplastic disease are often encountered in routine histopathology practice. Herein, we report a very rare case of pleural chronic inflammation with features suggestive for IgG4-related disease associated with the formation of a nest of mature, benign looking cartilage in the pleura of a middle age male patient. The review of the pertinent literature reveals that to date, only few cases of chondroid metaplasia or benign tumor (choristoma) are reported in mesothelium and only occasionally in this change is found in the pleura.
Copyright © 2019 Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology.

Entities:  

Keywords:  Chondroid metaplasia; Pleura; Stem cells

Mesh:

Substances:

Year:  2019        PMID: 31965113      PMCID: PMC8145668          DOI: 10.32074/1591-951X-1-19

Source DB:  PubMed          Journal:  Pathologica        ISSN: 0031-2983


Introduction

Mesothelium can react to different stimuli (of inflammatory, chemical, toxic, neoplastic origin) with inflammation, fibrosis necrosis and other degenerative changes. One of the most peculiar, albeit rarely seen changes is the development of mesenchymal derived tissues such as bone or cartilage. The pathogenesis of this condition is still not fully understood and further studies are needed in order to define the mechanisms at the origin of this rare form of metaplasia.

Case report

A 51-years-old male came to clinical attention for a five weeks history of breathlessness. The patient, who worked as a driver and in construction, had a significant smoking habit (30 cigarettes per day), diabetes, hypertension and high cholesterol blood levels under treatment. Imaging showed a moderate left pleural effusion with no evidence of specific features on CT. PET showed moderately avid lymph nodes in the paratracheal and AP window regions but no evidence of activity in the pleura (Fig. 1).
Fig. 1.

A and B: CT Thorax with contrast. Large left pleural effusion with underlying compression atelectasis of the basal segment of the left lower lobe and lingual; C and D: Post op Chest X-Ray showing progressive reduction of the effusion.

The thoracentesis drained 300 ml of blood stained fluid which showed no evidence of atypical/malignant cells on cytology examination. During the lung multidisciplinary meeting it was decided to proceed with thoracoscopic pleural biopsies and talc pleurodesis. The pleural biopsies were represented by multiple fragments of cream and yellow fat tissue with fibrotic consistency, measuring on aggregate up to 30 x 25 x 10 mm. The gross examination did not enlighten obvious pleural plaques or focal abnormalities. The tissue was entirely submitted for histological assessment. Microscopy examination showed reactive mesothelial tissue covering stroma and fat tissue with patchy fibrosis. The fibrotic tissue did not show storiform pattern, collagen necrosis or dysplasia. The fibrosis was associated with a moderate to severe chronic inflammation with a prominent plasma cell component and some pigment-laded histiocytes, but there was no evidence of granuloma formation. The fibrotic stroma showed areas of hyalinization and formation of cartilaginous tissue featuring bland, benign looking chondrocytes. There was no evidence of vasculitis, obliterative phlebitis, necrosis, dysplasia or malignancy. Immunohistochemistry and special stains confirmed the presence of reactive mesothelial cells (Calretinin and CKAE1/AE3 +), polytypic benign plasma cells (Kappa and Lambda chains stains +) and the absence of amyloid (Congo Red -). The presence of patchy areas of increased, polyclonal plasma cells associated with fibrosis raised the concern of a possible IgG4-related disease. The presence of the chondroid metaplasia itself did not influence this suspect as no data are available in literature to support a relationship between chondroid metaplasia and this entity. The stain for IgG4 showed an increased number of IgG4 + plasma cells focally up to 50 cells/HPF. In these fields the IgG4+/IgG ratio was occasionally more than 40% (Figg. 2-3). The overall appearance, together with the special stains and immunohistochemical features was compatible with moderate to severe chronic inflammation with features suggestive, but not entirely diagnostic for IgG4-related disease. However, the absence of diffuse fibrosis and phlebitis was not entirely supportive for a diagnosis of IgG4 related disease and serology levels were requested for confirmation. Serum IgG4 resulted within normal limits, thus excluding the diagnosis of IgG4-RD.

Discussion and review of literature

The most important features of this biopsy were the plasma cell rich chronic inflammation and the formation of ectopic chondroid tissue. Chondroid metaplasia is a relatively uncommon finding which has been described in different anatomical sites and conditions (both neoplastic and non-neoplastic), but is rarely reported in mesothelium [1] and even more occasionally in pleura. Chondroid metaplasia has been reported in tongue [2], head and neck [3-5], breast [67], lung [8] and brain [9]. Formation of ectopic, metaplastic cartilage in the mesothelium is rare and only a few cases are reported in the literature [10-15]. The pathogenesis of benign-looking cartilaginous tissue in mesothelium covered anatomic sites is still not fully understood. Some authors speculate that a population of sub-mesothelial pluripotent stem cells could differentiate towards mesenchymal and chondroid phenotypes [1113]. Other factors such as previous surgery, trauma, hemorrhage, abortion, ectopic pregnancies, teratomas or other neoplasms (both benign and malignant) have been considered as pathogenetic factors [10-12]. As shown in the Table the presence of metaplastic cartilaginous tissue is rare in pleura: in 1931 Klemperer et al. reported chondroid metaplasia in a series of pleural tumors [13] (although it was not possible to identify the exact number of metaplasia cases in this study), and in 2014 Walsh et al. reported a case of chondroid metaplasia within a rare pleural lipoma [14]. The present case is peculiar for its rarity and the lack of association with neoplasia. It presented itself as a focal area of well defined, mature and S-100 + cartilage on the background patchy, non storiform fibrosis and prominent lymphoplasmacellular inflammatory infiltrate. One of the most relevant features of our case is the association with several, polytypic active plasma cells which, in areas, were expressing the IgG4 phenotype. The presence of this specific plasma cellular phenotype raised the possibility of a systemic IgG4-related disease, thus clinical and serological correlation was strongly recommended in the histopathology report. The serology results came back as negative for pathologic IgG4 levels in blood, and thus a diagnosis of IgG4-Related disease was excluded. Our case showed only one of three histopathological criteria, but clinical and serological results were negative. The review of the pertinent literature [15-17] did not enlighten the development of chondroid metaplasia in the specific settings of IgG4-RD. However, it is possible that inflammatory-related molecules produced by activated plasma cells, or the specific micro-environment favored by the chronic inflammation may lead to a local increased expression of matrix and osteo-cartilaginous molecules (such as ostepontin, osteonectin, CD68, different cytokines and interleukins) which could promote the differentiation of fibroblasts and mesenchymal stem cells into the chondroid phenotype [1011151819]. A similar pathway is known in the development of heterotopic ossification in several organs (thyroid, soft tissue, gastro-intestinal and genito-urinary tracts) as a reactive/dystrophic reaction to many different neoplastic and non-neoplastic disorders including ischemia, necrosis, hemorrhage and fibrosis [19].

Conclusions

We report here a rare case of pleural cartilaginous metaplasia on the background of a chronic inflammation rich in IgG4+ plasma cells. Our case can be considered of interest for the rarity of the chondroid metaplasia itself and for its possible association with a chronic systemic inflammatory disease such as IgG4-RD. Only occasional cases of pleural chondroid metaplasia have been reported in the literature to the best of our knowledge and none was related with such a peculiar background. A and B: CT Thorax with contrast. Large left pleural effusion with underlying compression atelectasis of the basal segment of the left lower lobe and lingual; C and D: Post op Chest X-Ray showing progressive reduction of the effusion. A and B: Islands of chondroid metaplasia in the pleural tissue (H&E 2X); C: Chondroid tissue highlighted by S100 (IHC 4X); D: Lymphoplasmacellular infiltrate (H&E 2X); E and F: Inflammatory infiltrate IgG and IgG4 staining (2X). Magnification of the mature chondroid metaplastic tissue (H&E 10X). Chondroid metaplasia in mesothelium: review of literature.
Tab. I.

Chondroid metaplasia in mesothelium: review of literature.

AuthorYearSiteSurgery/traumaNo. of cases
Jacubowitz et al.1930PeritoneumNot knownNot known
Klemperer et al.1931PleuraNot knownNot known
Roth et al.1966Uterine serosaNot reported2
Fadare et al.2002PeritoneumNot reported2
Houang et al.2010Pelvic peritoneumYes1
Walsh et al.2014Pleura (within pleural lipoma)No1
Kaur et al.2017Pelvic peritoneum, broad ligamentYes1
Nwanze et al.2018Peritoneum surface at porta hepatisNo1
Franceschi et al.2018PeritoneumNot reported2
Present case2018PleuraNo1
  15 in total

1.  Chondroid metaplasia of the peritoneum.

Authors:  Michelle Houang; Harry Merkur; Peter Russell
Journal:  Pathology       Date:  2010       Impact factor: 5.306

Review 2.  IgG4-related disease: a complex under-diagnosed clinical entity.

Authors:  Sujani Yadlapati; Elijah Verheyen; Petros Efthimiou
Journal:  Rheumatol Int       Date:  2017-07-05       Impact factor: 2.631

3.  Metaplastic carcinoma with extensive chondroid differentiation in the breast (chondroid carcinoma).

Authors:  Yee-Jeong Kim; Hyo-Seob Shim; Hyde Lee; Woo-Hee Jung
Journal:  Yonsei Med J       Date:  2006-04-30       Impact factor: 2.759

4.  Chondroid nodule in the female peritoneum arises from normal tissue and not from teratoma or conception product.

Authors:  Tatiana Franceschi; Fabienne Allias; Claire Mauduit; Pierre-Adrien Bolze; Mojgan Devouassoux-Shisheboran
Journal:  Virchows Arch       Date:  2018-01-24       Impact factor: 4.064

5.  Chondroid Metaplasia in a Fibroepithelial Polyp of Gingiva.

Authors:  Fernando Tenorio; Paola Campos; Juan Ignacio Paramo; Javier De La Fuente; Nancy Pérez
Journal:  J Clin Diagn Res       Date:  2016-09-01

6.  Metaplastic Breast Carcinoma with Unusual Presentation: Review of Three Cases.

Authors:  M Asunción Fernández Pérez; Isabel Viqueira Rodriguez; Alberto Tello Royloa; Javier Martínez Guisasola
Journal:  Breast Care (Basel)       Date:  2015-11-18       Impact factor: 2.860

7.  The role of astrocytes in the formation of cartilage in gliomas. An immunohistochemical study of four cases.

Authors:  J J Kepes; L J Rubinstein; H Chiang
Journal:  Am J Pathol       Date:  1984-12       Impact factor: 4.307

Review 8.  IgG4-related disease and its pathogenesis-cross-talk between innate and acquired immunity.

Authors:  Hisanori Umehara; Akio Nakajima; Takuji Nakamura; Takafumi Kawanami; Masao Tanaka; Lingli Dong; Mitsuhiro Kawano
Journal:  Int Immunol       Date:  2014-07-14       Impact factor: 4.823

Review 9.  Overview of IgG4 - Related Disease.

Authors:  R Opriţă; B Opriţă; D Berceanu; I B Diaconescu
Journal:  J Med Life       Date:  2017 Oct-Dec

10.  Orthokeratinized odontogenic cyst of the mandible with heterotopic cartilage.

Authors:  Fumio Ide; Ichiro Saito; Norio Horie; Tetsuo Shimoyama
Journal:  Head Neck Pathol       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.